Literature DB >> 10732771

Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse.

K Vanderkerken1, C De Greef, K Asosingh, B Arteta, M De Veerman, I Vande Broek, I Van Riet, M Kobayashi, B Smedsrod, B Van Camp.   

Abstract

One of the main characteristics of multiple myeloma cells is their predominant localization in the bone marrow. It is, however, unclear whether this is due to a selective initial entry, or whether this entry is more random and other processes like survival and/or growth stimulation, only present in the medullar microenvironment, are unique. To investigate this, in vivo homing kinetics of murine 5T2MM cells shortly after injection were assessed in bone marrow, liver, spleen, lungs, heart, intestines, kidney and testis by tracing of radiolabelled cells, by immunostaining of isolated cells and by polymerase chain reaction analysis. We demonstrated the presence of 5T2MM cells in bone marrow, spleen and liver with all other organs being negative. Adhesion assays of 5T2MM cells to different types of endothelial cells demonstrated a selective adhesion of 5T2MM cells to bone marrow and liver and not to lung endothelial cells. We here demonstrate that the specific in vivo localization of the 5T2MM cells is a result of the combination of a selective entry/adhesion of the 5T2MM cells in the bone marrow, spleen and liver, and a selective survival and growth of these tumour cells in the bone marrow and spleen but not in the liver.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10732771      PMCID: PMC2374415          DOI: 10.1054/bjoc.1999.1024

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

1.  Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal.

Authors:  B Pope; R Brown; J Gibson; D Joshua
Journal:  Bone Marrow Transplant       Date:  1997-08       Impact factor: 5.483

2.  The migratory behavior of murine CD4+ cells of memory phenotype.

Authors:  W Tietz; A Hamann
Journal:  Eur J Immunol       Date:  1997-09       Impact factor: 5.532

3.  Through and beyond the wall: late steps in leukocyte transendothelial migration.

Authors:  E Bianchi; J R Bender; F Blasi; R Pardi
Journal:  Immunol Today       Date:  1997-12

4.  Preferential adhesion of fetal liver derived primitive haemopoietic progenitor cells to bone marrow stroma.

Authors:  A Blair; D B Thomas
Journal:  Br J Haematol       Date:  1997-12       Impact factor: 6.998

Review 5.  Multiple myeloma: increasing evidence for a multistep transformation process.

Authors:  M Hallek; P L Bergsagel; K C Anderson
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

6.  Interaction between human humoral factors and swine bone marrow cells (an experimental report).

Authors:  C C Bianchi de Di Risio; M Barbich; A Murua; S H Hyon; M I Beveraggi; P Argibay
Journal:  Transplant Proc       Date:  1997-06       Impact factor: 1.066

7.  Extramedullary hematopoiesis in the adult mouse liver is associated with specific hepatic sinusoidal endothelial cells.

Authors:  J E Cardier; E Barberá-Guillem
Journal:  Hepatology       Date:  1997-07       Impact factor: 17.425

8.  Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2).

Authors:  I Van Riet; C De Greef; F Aharchi; C Woischwill; M De Waele; M Bakkus; P Lacor; R Schots; B Van Camp
Journal:  Leukemia       Date:  1997-02       Impact factor: 11.528

9.  The gp 130 family cytokines IL-6, LIF and OSM but not IL-11 can reverse the anti-proliferative effect of dexamethasone on human myeloma cells.

Authors:  N Juge-Morineau; S François; D Puthier; A Godard; R Bataille; M Amiot
Journal:  Br J Haematol       Date:  1995-07       Impact factor: 6.998

10.  Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse.

Authors:  K Vanderkerken; H De Raeve; E Goes; S Van Meirvenne; J Radl; I Van Riet; K Thielemans; B Van Camp
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  18 in total

1.  Tumorigenic potential and disease manifestations of malignant B-cell variants differing in their fibronectin adhesiveness.

Authors:  Liat Nadav; Vyacheslav Kalchenko; Meir Max Barak; Elizabeth Naparstek; Benjamin Geiger; Ben-Zion Katz
Journal:  Exp Hematol       Date:  2008-08-09       Impact factor: 3.084

2.  Monocyte chemoattractant protein-1 (MCP-1), secreted by bone marrow endothelial cells, induces chemoattraction of 5T multiple myeloma cells.

Authors:  Karin Vanderkerken; Isabelle Vande Broek; Décio L Eizirik; Els Van Valckenborgh; Kewal Asosingh; Ivan Van Riet; Ben Van Camp
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

3.  Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features.

Authors:  Abdel Kareem Azab; Jinsong Hu; Phong Quang; Feda Azab; Costas Pitsillides; Rana Awwad; Brian Thompson; Patricia Maiso; Jessica D Sun; Charles P Hart; Aldo M Roccaro; Antonio Sacco; Hai T Ngo; Charles P Lin; Andrew L Kung; Ruben D Carrasco; Karin Vanderkerken; Irene M Ghobrial
Journal:  Blood       Date:  2012-03-06       Impact factor: 22.113

4.  Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.

Authors:  Eline Menu; Evy De Leenheer; Hendrik De Raeve; Les Coulton; Takeshi Imanishi; Kazuyuki Miyashita; Els Van Valckenborgh; Ivan Van Riet; Ben Van Camp; Richard Horuk; Peter Croucher; Karin Vanderkerken
Journal:  Clin Exp Metastasis       Date:  2006-11-03       Impact factor: 5.150

5.  Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model.

Authors:  Els Van Valckenborgh; Peter I Croucher; Hendrik De Raeve; Chris Carron; Evy De Leenheer; Sylvia Blacher; Laetitia Devy; Agnès Noël; Elke De Bruyne; Kewal Asosingh; Ivan Van Riet; Ben Van Camp; Karin Vanderkerken
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 6.  Extravasation and homing mechanisms in multiple myeloma.

Authors:  Isabelle Vande Broek; Karin Vanderkerken; Benjamin Van Camp; Ivan Van Riet
Journal:  Clin Exp Metastasis       Date:  2007-10-19       Impact factor: 5.150

7.  Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma.

Authors:  Kewal Asosingh; Eline Menu; Els Van Valckenborgh; Isabelle Vande Broek; Ivan Van Riet; Ben Van Camp; Karin Vanderkerken
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 8.  Bone metastasis: the importance of the neighbourhood.

Authors:  Peter I Croucher; Michelle M McDonald; T John Martin
Journal:  Nat Rev Cancer       Date:  2016-05-25       Impact factor: 60.716

9.  The new anti-actin agent dihydrohalichondramide reveals fenestrae-forming centers in hepatic endothelial cells.

Authors:  Filip Braet; Ilan Spector; Nava Shochet; Phillip Crews; Tatsuo Higa; Eline Menu; Ronald de Zanger; Eddie Wisse
Journal:  BMC Cell Biol       Date:  2002-03-21       Impact factor: 4.241

10.  A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease.

Authors:  Peter O Hofgaard; Henriette C Jodal; Kurt Bommert; Bertrand Huard; Jo Caers; Harald Carlsen; Rolf Schwarzer; Nicole Schünemann; Franziska Jundt; Mona M Lindeberg; Bjarne Bogen
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.